ESMO 2022 Conference Coverage

 

Head and Neck
03:03

ESMO 2022 Conference Coverage

Lecture Summary - ESMO 2022 on the IT-MATTERS Study: Early Response to Leukocyte Interleukin Injection IO Extends OS in Locally Advanced Primary HNSCC

FEATURING Philip Lavin
  • 3 views
  • October 3, 2022
14:06

ESMO 2022 Conference Coverage

ESMO 2022 on the IT-MATTERS Study: Early Response to Leukocyte Interleukin Injection IO Extends OS in Locally Advanced Primary HNSCC

FEATURING Philip Lavin
  • 163 views
  • October 3, 2022
  • 1
10:16

ESMO 2022 Conference Coverage

ESMO 2022 H&N Updates

FEATURING Nabil Saba
  • 779 views
  • September 30, 2022
  • 5
48

ESMO 2022 Conference Coverage

Lecture Summary - ESMO 2022 on the Phase 4 KEYNOTE-B10 Study: Pembro + Carbo + Paclitaxel as 1L Therapy in Recurrent/Metastatic HNSCC

FEATURING Marcin Dzienis
  • 2 views
  • September 30, 2022
06:12

ESMO 2022 Conference Coverage

ESMO 2022 on the Phase 4 KEYNOTE-B10 Study: Pembro + Carbo + Paclitaxel as 1L Therapy in Recurrent/Metastatic HNSCC

FEATURING Marcin Dzienis
  • 55 views
  • September 30, 2022
  • 1
06:03

ESMO 2022 Conference Coverage

ESMO 2022: Contemporary Approach to the Multidisciplinary Management of Sinonasal Cancer

FEATURING Paolo Bossi
  • 43 views
  • September 22, 2022
  • 1
35

ESMO 2022 Conference Coverage

Lecture Summary - ESMO 2022 Updates on the Randomized Phase III VANCE Study: Gem & Carbo Followed by Epstein-Barr Virus-Specific Autologous Cytotoxic T-Lymphocytes vs. the Same Chemo as 1L Treatment for Advanced Nasopharyngeal Carcinoma

FEATURING Han Chong Toh
  • 4 views
  • September 22, 2022
10:12

ESMO 2022 Conference Coverage

ESMO 2022 Updates on the Randomized Phase III VANCE Study: Gem & Carbo Followed by Epstein-Barr Virus-Specific Autologous Cytotoxic T-Lymphocytes vs. the Same Chemo as 1L Treatment for Advanced Nasopharyngeal Carcinoma

FEATURING Han Chong Toh
  • 51 views
  • September 22, 2022
01:48

ESMO 2022 Conference Coverage

Lecture Summary - ESMO 2022 on Multi-Omic Profiling in H&N Cancer: Clinical Applications

FEATURING Inge Tinhofer
  • 3 views
  • September 21, 2022
17:08

ESMO 2022 Conference Coverage

ESMO 2022 on Multi-Omic Profiling in H&N Cancer: Clinical Applications

FEATURING Inge Tinhofer
  • 74 views
  • September 21, 2022
  • 1
05:46

ESMO 2022 Conference Coverage

ESMO 2022: NGS Helps Predict Response to IO in Recurrent/Metastatic HNSCC Patients

FEATURING Oriol Mirallas
  • 206 views
  • September 19, 2022
  • 1
05:19

ESMO 2022 Conference Coverage

ESMO 2022 Evaluation of the DNA Damage Response Network as a Predictor of Nivolumab Efficacy in HNSCC

FEATURING Panagiota Oikonomopoulou
  • 86 views
  • September 19, 2022
  • 1
04:03

ESMO 2022 Conference Coverage

ESMO 2022 on the EPOCKS Study: Exclusive CRT & Surgery or Induction Chemo as Initial Curative Treatment for Localized/Locally Advanced HNSCC

FEATURING Jérome Fayette
  • 133 views
  • September 15, 2022
  • 1
05:50

ESMO 2022 Conference Coverage

ESMO 2022 Liquid Biopsy for Detection of Molecular Residual Disease and Recurrence in Head and Neck Squamous Cell Carcinoma

FEATURING Susanne Flach
  • 81 views
  • September 14, 2022
  • 1